by Year
NEWS 2023
-
December 21, 2023 R & D PDF266 KB
-
November 13, 2023 Management & Finance PDF279 KB
-
November 13, 2023 Management & Finance
Outline of Consolidated Financial Results for the Second Quarter Ended September 30, 2023
-
October 27, 2023 Management & Finance PDF379 KB
-
October 17, 2023 R & D PDF324 KB
NS-089/NCNP-02: Preclinical data published in Molecular Therapy Nucleic Acids
-
August 28, 2023 R & D PDF268 KB
-
August 10, 2023 Management & Finance
Outline of Consolidated Financial Results for the First Quarter Ended June 30, 2023
-
August 08, 2023 R & D PDF235 KB
-
August 07, 2023 R & D PDF262 KB
-
July 28, 2023 R & D PDF264 KB
-
July 14, 2023 Corporate PDF259 KB
Nippon Shinyaku Selected as a Constituent of the FTSE Blossom Japan Index
-
July 04, 2023 R & D PDF261 KB
-
June 27, 2023 R & D PDF269 KB
-
June 21, 2023 R & D PDF273 KB
-
June 02, 2023 Notices
-
May 11, 2023 Management & Finance
Outline of Consolidated Financial Results for the Year Ended March 31, 2023
-
May 09, 2023 R & D PDF241 KB
-
April 14, 2023 R & D PDF234 KB
-
March 22, 2023 Corporate PDF226 KB
Nippon Shinyaku Provides Support for the Earthquake in Turkey and Syria
-
March 15, 2023 Pharmaceuticals PDF309 KB
Launch of MonoVer® for I.V. injection 500mg/1000mg for the treatment of iron deficiency anemia
-
February 16, 2023 R & D PDF244 KB
-
February 10, 2023 Management & Finance
Outline of Consolidated Financial Results for the Third Quarter Ended December 31, 2022
-
January 06, 2023 Corporate PDF258 KB
The opening of "Innovation Research Partnering," a drug discovery center in the U.S.